SoftBank Vision Fund 2 led a $100m series C round for the healthcare data analytics provider that included existing investor MassMutual Ventures.
US-based healthcare analytics provider Biofourmis completed a $100m series C round today led by internet and telecommunciations group SoftBank’s Vision Fund 2.
MassMutual Ventures, the corporate venture capital arm of insurance firm Massachusetts Mutual Life Insurance, also took part in the round, as did Singaporean state-owned investment fund EDBI and venture capital firms Openspace Ventures and Sequoia Capital.
Biofourmis has created an artificial intelligence-equipped software platform that analyses health data to help physicians to provide personalised predictive care for conditions…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
